BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 2848629)

  • 1. Combined treatment with interferon (IFN)-gamma and tumor necrosis factor (TNF)-alpha up-regulates the expression of HLA class I determinants in Burkitt lymphoma lines.
    Avila-Carino J; Torsteinsdottir S; Bejarano MT; Klein G; Klein E; Masucci MG
    Cell Immunol; 1988 Dec; 117(2):303-11. PubMed ID: 2848629
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Down-regulation of class I HLA antigens and of the Epstein-Barr virus-encoded latent membrane protein in Burkitt lymphoma lines.
    Masucci MG; Torsteindottir S; Colombani J; Brautbar C; Klein E; Klein G
    Proc Natl Acad Sci U S A; 1987 Jul; 84(13):4567-71. PubMed ID: 3037521
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Restoration of endogenous antigen processing in Burkitt's lymphoma cells by Epstein-Barr virus latent membrane protein-1: coordinate up-regulation of peptide transporters and HLA-class I antigen expression.
    Rowe M; Khanna R; Jacob CA; Argaet V; Kelly A; Powis S; Belich M; Croom-Carter D; Lee S; Burrows SR
    Eur J Immunol; 1995 May; 25(5):1374-84. PubMed ID: 7774641
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immune escape by Epstein-Barr virus (EBV) carrying Burkitt's lymphoma: in vitro reconstitution of sensitivity to EBV-specific cytotoxic T cells.
    Masucci MG; Zhang QJ; Gavioli R; De Campos-Lima PO; Murray RJ; Brooks J; Griffin H; Ploegh H; Rickinson AB
    Int Immunol; 1992 Nov; 4(11):1283-92. PubMed ID: 1282031
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recognition of the Epstein-Barr virus-encoded nuclear antigens EBNA-4 and EBNA-6 by HLA-A11-restricted cytotoxic T lymphocytes: implications for down-regulation of HLA-A11 in Burkitt lymphoma.
    Gavioli R; De Campos-Lima PO; Kurilla MG; Kieff E; Klein G; Masucci MG
    Proc Natl Acad Sci U S A; 1992 Jul; 89(13):5862-6. PubMed ID: 1321426
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aberrant expression of HLA class-I antigens in Burkitt lymphoma cells.
    Andersson ML; Stam NJ; Klein G; Ploegh HL; Masucci MG
    Int J Cancer; 1991 Feb; 47(4):544-50. PubMed ID: 1899854
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential expression of HLA antigens on human B-cell lines of normal and malignant origin: a consequence of immune surveillance or a phenotypic vestige of the progenitor cells?
    Torsteinsdottir S; Brautbar C; Klein G; Klein E; Masucci MG
    Int J Cancer; 1988 Jun; 41(6):913-9. PubMed ID: 2453477
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Allele-specific down-regulation of MHC class I antigens in Burkitt lymphoma lines.
    Masucci MG; Stam NJ; Torsteinsdottir S; Neefjes JJ; Klein G; Ploegh HL
    Cell Immunol; 1989 May; 120(2):396-400. PubMed ID: 2541930
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Selective induction of allostimulatory capacity after 5-azaC treatment of EBV carrying but not EBV negative Burkitt lymphoma cell lines.
    Cuomo L; Trivedi P; de Campos-Lima PO; Zhang QJ; Ragnar E; Klein G; Masucci MG
    Mol Immunol; 1993 Apr; 30(5):441-50. PubMed ID: 7681932
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differentiation-dependent sensitivity of human B-cell-derived lines to major histocompatibility complex-restricted T-cell cytotoxicity.
    Torsteinsdottir S; Masucci MG; Ehlin-Henriksson B; Brautbar C; Ben Bassat H; Klein G; Klein E
    Proc Natl Acad Sci U S A; 1986 Aug; 83(15):5620-4. PubMed ID: 3016710
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Restoration of the LFA-3 adhesion pathway in Burkitt's lymphoma cells using an LFA-3 recombinant vaccinia virus: consequences for T cell recognition.
    Griffin H; Rowe M; Murray R; Brooks J; Rickinson A
    Eur J Immunol; 1992 Jul; 22(7):1741-8. PubMed ID: 1378014
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanisms of allele-selective down-regulation of HLA class I in Burkitt's lymphoma.
    Imreh MP; Zhang QJ; de Campos-Lima PO; Imreh S; Krausa P; Browning M; Klein G; Masucci MG
    Int J Cancer; 1995 Jul; 62(1):90-6. PubMed ID: 7601573
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lymphotoxin acts as an autocrine growth factor for Epstein-Barr virus-transformed B cells and differentiated Burkitt lymphoma cell lines.
    Gibbons DL; Rowe M; Cope AP; Feldmann M; Brennan FM
    Eur J Immunol; 1994 Aug; 24(8):1879-85. PubMed ID: 8056047
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stimulation with allogeneic Epstein-Barr virus-transformed lymphoblastoid cell lines generates HLA class I-specific CTLs with different target cell avidity.
    Torsteinsdottir S; Cuomo L; Klein E; Masucci MG
    Cell Immunol; 1991 Oct; 137(2):501-13. PubMed ID: 1654213
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Paired Epstein-Barr virus-carrying lymphoma and lymphoblastoid cell lines from Burkitt's lymphoma patients: comparative sensitivity to non-specific and to allo-specific cytotoxic responses in vitro.
    Rooney CM; Rickinson AB; Moss DJ; Lenoir GM; Epstein MA
    Int J Cancer; 1984 Sep; 34(3):339-48. PubMed ID: 6090321
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Defective presentation of MHC class I-restricted cytotoxic T-cell epitopes in Burkitt's lymphoma cells.
    Frisan T; Zhang QJ; Levitskaya J; Coram M; Kurilla MG; Masucci MG
    Int J Cancer; 1996 Oct; 68(2):251-8. PubMed ID: 8900437
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cell-mediated immunosurveillance mechanisms and the pathogenesis of Burkitt's lymphoma.
    Rooney CM; Rickinson AB; Moss DJ; Lenoir GM; Epstein MA
    IARC Sci Publ; 1985; (60):249-64. PubMed ID: 2998992
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of class I major histocompatibility complex antigens in Epstein-Barr virus-carrying lymphoblastoid cell lines and Burkitt lymphoma cells.
    Jilg W; Voltz R; Markert-Hahn C; Mairhofer H; Münz I; Wolf H
    Cancer Res; 1991 Jan; 51(1):27-32. PubMed ID: 1899042
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A monoclonal antibody with anti-Burkitt lymphoma specificity. I. Analysis of human haematopoietic and lymphoid cell lines.
    Wiels J; Lenoir GM; Fellous M; Lipinski M; Salomon JC; Tetaud C; Tursz T
    Int J Cancer; 1982 Jun; 29(6):653-8. PubMed ID: 6286514
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Generation of HLA-B55 restricted T lymphocyte mediated cytotoxicity against autologous LCL.
    Avila-Cariño J; Végh Z; Klein E
    Mol Immunol; 1994 Jan; 31(1):59-63. PubMed ID: 8302299
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.